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Magnetic nanoclusters (MNCs) are agglomerated individual magnetic nanoparticles (MNPs) that show great promise
in increasing magnetic resonance imaging (MRI) sensitivity. Here, we report an effective strategy to engineer MNCs
based on double-ligand modulation to enhance MRI sensitivity. The oleic acid-coated individual MNPs self-
assembled and then were enveloped by polysorbate 80, using a nanoemulsion method to prepare MNCs. By
modulating the amounts of the two ligands, and thus the size and magnetic content of the resultant MNCs, we
were able to enormously improve MRI sensitivity.
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Magnetic resonance imaging (MRI) is a powerful im-
aging tool for clinical diagnosis due to noninvasive
tomographic imaging potentials with high spatial reso-
lution [1-5]. In particular, MRI using magnetic
nanoparticles (MNPs) conjugated to a targeting moiety
is a highly attractive approach for the molecular imaging
of cancer-specific biomarkers. This is because the T2-
shortening effect of MNPs results in dark contrast
[5-13]. Studies aimed at increasing T2 MRI sensitivity
report that increasing the magnetization value by size
growth and metal doping enhances the T2 shortening ef-
fect [8-10]. However, the size increase induced the
superparamagnetic-ferromagnetic transition, so resulting
MNPs were no longer suitable as MRI contrast agents.
Recent efforts in nanocrystal synthesis have shifted to
secondary structure manipulation to upgrade the prop-
erties of individual nanocrystals based on interactions
between their subunits [14-18]. Magnetic nanoclusters
(MNCs) as a secondary structure are composed of
assembled MNPs that reportedly can act as contrast* Correspondence: ymhuh@yuhs.ac; haam@yonsei.ac.kr
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in any medium, provided the original work is pagents to improve T2 MRI capability. Precisely, MNCs
showed higher T2 relaxivity and a larger darkening effect
than individual MNPs because they possess higher
magnetization per particle with superparamagnetic prop-
erty [19-24]. MNCs have been fabricated either by self-
assembly or through direct solution growth. The common
goal of these synthetic methods was to control the size of
MNCs because T2 relaxivity increases are proportional to
particle size [23,24]. However, the signal enhancement
provided by MNCs still remains unsatisfactory because
the studies about the density of individual MNPs
consisting MNCs have not been concerned yet. Thus, a
primary issue in MNC fabrication is to optimally increase
magnetic content in concert with particle enlargement to
improve T2 relaxivity.
Herein, we developed an effective strategy to selectively
engineer MNC particle size and magnetic content, using a
double-ligand modulation approach, to enhance T2 MRI
signal intensity. First, high-quality MNPs exhibiting strong
nanomagnetism were synthesized by thermal decompos-
ition. High-quality MNPs composed MNCs to derive ef-
fective enhancement of MNC T2 relaxivity. Second, a
series of MNPs possessing various weight percent of oleic
acid (primary ligand) was prepared. This allowed us to
control MNP-MNP distances when these particles were
combined to create MNC agglomerates, thereby regulating
MNC density to our desired specifications. Finally, primaryOpen Access article distributed under the terms of the Creative Commons
g/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction
roperly cited.
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using polysorbate 80 (secondary ligand) by nanoemulsion
to construct MNCs. During nanoemulsion, various
MNC sizes were fabricated by manipulating the con-
centration of polysorbate 80 employed. Subsequently,
we compared the T2 relaxivity of these different MNCs to
assess the optimal synthesis conditions for achieving opti-
mal T2 signal enhancement. A conceptual scheme of the
double-ligand modulation strategy for engineering MNCs
is shown in Figure 1.
Methods
Materials
Iron(III) chloride hexahydrate, sodium oleate, oleic acid,
1-octadecene, and polysorbate 80 (polyoxyethylene sorb-
itan mono-oleate) were purchased from Sigma-Aldrich
Co. (St. Louis, MO, USA). All other chemicals and re-
agents were of analytical grade.
Synthesis of iron-oleate complex
Iron-oleate complex was prepared by reacting iron chlor-
ide and sodium oleate. For the synthesis, 10.8 g (40 mmol)Figure 1 Schematic illustration for engineering MNCs based on doubiron chloride and 36.5 g (120 mmol) sodium oleate were
dissolved in a mixed solvent composed of 80 mL ethanol,
60 mL deionized water, and 140 mL n-hexane. The
resulting solution was heated to 70°C for 4 h. When the
reaction was completed, the upper organic layer con-
taining the iron-oleate complex was washed three times
with 30 mL deionized water, using a separation funnel.
After washing, residual n-hexane was evaporated off, leav-
ing the iron-oleate complex as a waxy solid [25].Synthesis of iron oxide MNPs
Thirty-six grams (40 mmol) of the synthesized iron-
oleate complex and 5.7 g (20 mmol) oleic acid were
dissolved in 200 g 1-octadecene at room temperature.
The resulting solution was heated to 320°C with a
constant heating rate of 3.3°C min−1, and then reacted
at 320°C for 30 min. The resulting solution con-
taining the MNPs was cooled to room temperature,
and 500 mL ethanol was added to the solution. The
MNPs were purified by centrifugation and resuspended in
n-hexane [25,26].le-ligand modulation.
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containing various amounts of oleic acid (primary-ligand
modulation)
Excess oleic acid was removed from synthesized MNPs
by ethanol precipitation. Fifty milliliters of ethanol was
added to the 50 mg MNPs dissolved in 5 mL n-hexane,
and the resulting mixture was sonicated at 190 W for 20
min. After sonication, MNPs were separated by centrifu-
gation (99×g, 10 min) and resuspended in 5 mL n-hexane.
After ethanol precipitation, primary ligand-modulated
MNPs (PMNPs) containing the lowest amount of oleic
acid (LMNPs) were obtained, and the other PMNPs
containing medium (MMNPs) and the highest (HMNPs)
amount of oleic acid were prepared by adding pure oleic
acid to the LMNPs.
Preparation of MNCs by the nanoemulsion method
(secondary-ligand modulation)
Four milliliters of n-hexane containing 10 mg LMNPs was
added to 20 mL deionized water containing 100, 50, 25, or
10 mg polysorbate 80. After mutual saturation of the or-
ganic and aqueous phases, the mixture was sonicated for
20 min at 190 W with vigorous stirring. After sonication,
the organic solvent was evaporated rapidly using a rotary
evaporator to form MNCs. The other PMNPs (MMNPs
and HMNPs) were similarly used to prepare MNCs by the
identical nanoemulsion method [27].
Magnetic resonance imaging
Magnetic resonance imaging experiments were performed
with a 1.5-T clinical MRI instrument with a Micro-47
surface coil (Intera, Philips Medical Systems, Amsterdam,
The Netherlands). T2 relaxivity (r2 (s−1 mM−1); ratio of
R2 (1/T2) to iron concentration) of MNCs was measured
at room temperature by the Carr-Purcell-Meiboom-Gill
sequence: TR = 10 s, 32 echoes, with 12 ms even echo
space, number of acquisitions = 1, point resolution
156 × 156 μm, section thickness 0.6 mm.
Characterization
The morphology and the size of MNPs were analyzed
using a transmission electron microscope (JEM-2100
LAB6, JEOL Ltd., Akishima-shi, Japan), and the crystal-
lographic structure of MNPs was obtained from X-ray
diffraction patterns (D/MAX Ultima III, Rigaku Co.,
Shibuya-ku, Japan). The characteristic bands of pure oleic
acid and MNPs were evaluated by Fourier transform infra-
red spectroscopy (FT-IR; Excalibur Series, Varian Inc.,
Palo Alto, CA, USA) to confirm the existence of oleic acid
on the MNPs. The amount of oleic acid on the MNPs was
quantified using a thermogravimetric analyzer (SDT-
Q600, TA Instruments, New Castle, DE, USA). The MNC
size (hydrodynamic diameter) was analyzed by laser scat-
tering (ELS-Z, Otsuka Electronics, Hirakata-shi, Japan).The Fe concentration in MNCs was quantified by induct-
ively coupled plasma atomic emission spectrometry
(Thermo Electron Corporation, Waltham, MA, USA).
Results and discussion
High-quality MNPs in terms of size uniformity, single
crystallinity, and high magnetism should be verified first
as a part of the building blocks that comprise the MNCs.
This guarantees repeatability in experiments aimed to
determine optimal enhancement of MNC T2 relaxivity.
For particle uniformity, MNPs were synthesized by a
thermal decomposition method using an iron-oleate as
the precursor and oleic acid as the primary ligand [25].
The narrow size distribution (7.8 ± 0.5 nm) and the
spherical morphology of the MNPs were ascertained by
transmission electron microscopy (Figure 2a). The highly
crystalline MNP structure was confirmed by the X-ray
powder diffraction pattern assigned at 2θ values of 30°
(220), 36° (311), 44° (400), 58° (511), and 63° (440),
which indicated the inverse spinel structure of magnetite
(Fe3O4; JCPDS no. 19–0629; Additional file 1: Figure
S1a). Moreover, the MNPs exhibited the saturation
magnetization value of 87 emu g−1 Fe at 1.0 T without
magnetic hysteresis (Additional file 1: Figure S1b).
To control MNP clustering synthesis, the amount of
oleic acid on the synthesized MNPs should be first mod-
ulated. This is necessary because the amount of oleic
acid affects MNC formation. Steric repulsion among the
hydrocarbon tails of oleic acid on individual MNPs im-
pacts assembly capability of individual MNPs. To modify
the amount of oleic acid on the MNPs, the MNPs were
dissolved in n-hexane and ethanol was added to the solu-
tion to remove part of the oleic acid coating. Finally, three
samples of PMNPs were successfully obtained from
the precipitates [25,26], each coated with different oleic
acid amounts: 19 (low PMNPs, LMNPs), 33 (medium
PMNPs, MMNPs), and 46 (high PMNPs, HMNPs) wt.%
(Figure 2b).
To investigate the effect of primary ligand on MNCs,
the interactions of oleic acid molecules on the surface of
MNPs were analyzed through derivative weight curves
of the three samples of PMNPs (Figure 2c). These
PMNPs showed three derivative peaks positioned be-
tween 25°C and 550°C [28-30]. The first peak positioned
at approximately 250°C (Figure 2c, i) was due to the re-
moval of free oleic acid molecules surrounding the
MNPs (Figure 2d, i), consistent with the derivative peak
of pure oleic acid (Additional file 1: Figure S2). The sec-
ond peak positioned at approximately 350°C (Figure 2c,
ii), which was close to the boiling temperature of oleic
acid, indicated bilayered oleic acid molecules with
hydrophobic interactions between hydrocarbon tails
(Figure 2d, ii). The third peak at approximately 450°C
(Figure 2c, iii) corresponded to oleic acid molecules
Figure 2 Characterization of PMNPs. (a) Transmission electron microscopy image of MNPs. (b) Thermogravimetric analysis shows weight
change in relation to temperature of the three PMNPs containing different amounts of primary ligand (oleic acid). (c) Derivative weight curves of
the three PMNPs (LMNPs, MMNPs, and HMNPs). (d) Illustration of the interactions of oleic acid on MNPs.
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teristic peaks of the oleic acid-MNP conjugates from
asymmetric and symmetric COO− stretches of oleic acid
(1,630 and 1,532 cm−1) were confirmed by FT-IR spec-
troscopy (Additional file 1: Figure S3 and Table S1) and
were categorized as a chelating bidentate complex: peak
separation as 98 cm−1 = 1,630 to 1,532 cm−1 (Additional
file 1: Table S2) [30,31]. The derivative weight curve of
an iron-oleate precursor used for MNP synthesis also
agreed with the derivative peaks of PMNPs (Additional
file 1: Figure S4). From these results, it was determined
that LMNPs contained mostly surface-bound oleic acid
molecules showing a sharp peak approximately 450°C
(Figure 2c, red line). Increased oleic acid in MMNPs
formed a surface bilayer, which showed as an additional
derivative peak at approximately 350°C (Figure 2c, blue
line). The appearance of a sharp peak at approximately
250°C in HMNPs represented excess free oleic acid mol-
ecules (Figure 2c, black line). Therefore, we expected
that (1) LMNPs were more likely to agglomerate andform large dense MNCs, (2) MMNPs would undergo
less self-assembly and form smaller MNCs compared
with LMNPs, and (3) excess free oleic acid in HMNPs
would disrupt the assembly of individual MNPs to
form MNCs.
Following primary-ligand modulation, PMNPs were
then emulsified with the nanoemulsion method, using
polysorbate 80 as a secondary ligand to fabricate MNCs.
The nanoemulsion was created by dropwise injection of
a PMNP-laden organic solvent phase into an aqueous
continuous phase, followed by ultrasonication and vigor-
ous stirring. The nanoemulsion surface was then stabi-
lized using polysorbate 80 dissolved in an aqueous
phase. The PMNPs within the nanoemulsion assembled
and packed into MNCs during solvent evaporation
[23,27,32]. To control MNC size for maximizing T2
relaxivity, the polysorbate 80 concentration was adjusted.
Polysorbate 80 is a surfactant that decreases MNC size
by reducing emulsion surface tension. Therefore, the
three PMNP samples were each emulsified with various
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24-mL total reaction volume).
We compared the effect of varying oleic acid and poly-
sorbate 80 concentrations on engineered MNC size, as de-
termined by laser scattering. In Figure 3a, LMNPs formed
larger MNCs at each polysorbate 80 concentration, than
did the other two PMNPs. This is because LMNPs are
coated with the least amount of oleic acid and thus
possess the lowest level of steric repulsion between MNPs.
This allows LMNPs to easily agglomerate to form the
largest MNCs [33,34]. The increased oleic acid on
MMNPs hindered the clustering of individual MNPs,
resulting in smaller MNCs compared with LMNPs. The
additional oleic acid molecules on HMNPs resulted in
slightly bigger sized MNCs than MMNPs due to oily space
occupied by excess oleic acid, at all polysorbate concentra-
tions tested (detailed values for MNC sizes are presented
in Additional file 1: Table S3). These results agreed with
the observations of the derivative weight curves and dem-
onstrated that primary-ligand (oleic acid) modulation of
MNPs considerably affected final MNC size.Figure 3 Characterization of MNCs fabricated from three PMNPs. (a) T
MNC solutions in the cubic cell and solution MRIs (0.74 mM Fe).With all three PMNPs, increasing the polysorbate 80
concentration caused a decrease in final MNC size
(Figure 3a). When polysorbate 80, a surfactant, was con-
centrated enough to cover large surface areas, MNP
interfacial energy was sufficiently lowered to cause for-
mation of smaller MNCs. By contrast, low polysorbate
80 concentrations insufficiently stabilized the entire
MNP surface area and allowed nanoemulsion aggrega-
tion to form larger MNCs [23,35]. Thus, MNC size is
easily regulated by modulating the amount of secondary
ligand (polysorbate 80).
We then investigated the T2 relaxivity (r2) of variously
sized MNCs created by double-ligand modulation, using a
1.5-T MRI instrument (Figure 3b). Magnetic nanoclusters
fabricated from LMNPs exhibited a threefold higher r2
value compared to MNCs generated from MMNPs and
HMNPs. This effect was due to the larger MNC size and
greater density of these MNCs. Magnetic nanoclusters
composed of MMNPs exhibited higher r2 values than
MNCs created from HMNPs, when 10 and 25 mg poly-
sorbate 80 were employed. The MNCs fabricated fromhe size and (b) T2 relaxivity (r2) of MNCs. (c) Representative images of
Figure 4 The r2(S) (r2 enhancement divided by size increase of
MNCs) for each PMNP.
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MNCs generated from HMNPs. At 50 and 100 mg poly-
sorbate 80, however, MNCs fabricated from MMNPs and
HMNPs showed no noticeable distinction in r2 values.
The difference of oleic acid content in these two PMNPs
is insufficient to differentiate the size and magnetic con-
tent of MNCs when high concentrations of polysorbate 80
are employed in the reaction. At excess polysorbate 80
concentrations, polysorbate 80 stabilized the MNCs to
form quite small ones.
The MNC r2 value variations observed when using a
constant amount of polysorbate 80 were derived by
primary-ligand modulation. Additionally, the increased
r2 values in concert with decreased polysorbate 80 con-
centrations in the reaction were caused by MNC size in-
creases due to the effect of secondary-ligand modulation
[23]. Thus, these results demonstrate that modulation of
both primary and secondary ligands is crucial for engin-
eering MNCs to provide maximally enhanced MRI sensi-
tivity. The r2 values of MNCs created from LMNPs using
low amount of polysorbate 80 (10 and 25 mg) were not
measurable because unstable MNCs were aggregated
under an external magnetic field. Detailed MNC r2 values
are presented in Additional file 1: Table S3.
Figure 3c shows photographs of MNCs dispersed in
water and their T2-weighted solution MRIs. MNCs pre-
pared from MMNPs and HMNPs were well dispersed in
water without sedimentation, whereas LMNPs showed ag-
gregation with larger cluster size that gradually settled
over time. This indicates that insufficient polysorbate 80
concentrations were employed to form stable nanoclusters
(Additional file 1: Figure S5). In addition, T2-weighted
solution MRIs of MNCs obtained at the same iron con-
centration (0.74 Fe mM) showed darker images with de-
creased amount of polysorbate 80. Importantly, MNCs
fabricated from LMNPs showed the strongest darkening
effect. From these results, in our system, we determined
that MNCs fabricated from LMNPs using 50 mg polysor-
bate 80 exhibited good solubility and provided the greatest
enhancement of MRI sensitivity.
To investigate the efficiency of the engineered MNCs
prepared by double-ligand modulation, we defined
another form of relaxivity (r2(S)) that referred the r2 en-
hancement property based on size increase of MNCs.
The r2 enhancement for each PMNP (107.8 ~ 68.5 s−1
mM−1 for LMNPs, 102.7 ~ 19.2 s−1 mM−1 for MMNPs,
44.3 ~ 19.3 s−1 mM−1 for HMNPs) were divided by size
increase (59.9 ~ 42.6 nm for LMNPs, 65.1 ~ 15.8 nm for
MMNPs, 66.6 ~ 17.1 nm for HMNPs). The r2(S) values
thus obtained were 2.3, 1.7, and 0.5 s−1 mM−1 nm−1 for
LMNPs, MMNPs, and HMNPs, respectively (Figure 4).
The positive value of r2(S) indicated that MNC r2 en-
hancement was related to MNC size increase in associ-
ation with using decreasing polysorbate 80 concentrationsas the secondary-ligand modulation. However, the differ-
ence in r2(S) among LMNPs, MMNPs, and HMNPs meant
that the efficiency of the r2 enhancement through the en-
gineering of MNCs depended on the primary-ligand
modulation. Precisely, LMNPs possessed the highest r2(S)
(2.3 s−1 mM−1 nm−1), indicating that LMNPs were the
most effective for creating MNCs with enhanced r2
values. Taken together, these results defined the precise
primary and secondary ligand concentrations that work
together to produce MNCs that are of optimal size and
magnetic content for enhancing MRI r2 values.Conclusions
We successfully engineered MNCs based on double-
ligand modulation to act as contrast agents and signifi-
cantly enhance MRI sensitivity. The functions of primary
and secondary ligands during MNC synthesis could be
independently controlled by stepwise modulation pro-
cesses. The density of individual MNPs in the MNCs
was increased by decreasing the amount of oleic acid on
the MNPs (primary-ligand modulation), and MNC size
was increased by reducing the concentration of polysor-
bate 80 (secondary-ligand modulation). Together, these
two effects effectively increase MNC r2 values. Our new
MNC fabrication strategy using double-ligand modula-
tion overcomes the limitation of MNC generation by
single-ligand modulation alone and allows the precise
regulation of MNC size, density, and magnetic proper-
ties to optimally enhance MRI. Moreover, our investiga-
tion provided a versatile and powerful model to engineer
various secondary structures of diverse nanocrystals and
to subsequently evaluate their physical properties.
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acid and MNPs (detailed analysis is presented in Table S1). S4. (a)
Derivative weight curve of Fe-oleate precursor, (b) illustration for the
interactions of oleic acid in Fe-oleate precursor. S5. Representative
images of MNCs solution in the cubic cell according to the time of 0
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